The NCDR and Clinical Practice Guideline Development

Size: px
Start display at page:

Download "The NCDR and Clinical Practice Guideline Development"

Transcription

1 The NCDR and Clinical Practice Guideline Development Gregory J. Dehmer, MD, FACC, FACP, FSCAI Professor of Medicine Texas A&M HSC College of Medicine Director, Cardiology Division Baylor Scott & White Health, Central Texas Guidelines These Days, We Have Many Sources of Information that Provide Structure Around the Practice of Cardiology Where and how does the NCDR fit in? The NCDR and Clinical Practice Guidelines Clinical Studies Adapted from: Antman & Peterson, Circulation 2009:119:

2 Clinical Practice Guidelines (CPGs) Before the 1980 s physicians relied upon experience and intuition to guide patient care First ever guideline was in 1984 J Am Coll Cardiol 1984; 4: Clinical Practice Guidelines (CPGs) ACC/AHA partner with other professional organizations to provides guidelines and other documents Rely on evidencebased care/randomized trials If no evidence available, expert opinion Clinical Practice Guidelines Clinical Practice Guidelines (CPG) (State of Science) Exhaustive review of the literature and knowledge base Heavy reliance on RCTs, if any Best practices Should do, should not do Class I = you should do this Class III = don t do this no benefit or harm Class II = conflicting data Maybe OK, sometimes (we re not sure, need more research, debatable, etc...) Level of evidence A: multiple populations studied, multiple RCT, meta-analyses B: limited populations, one RCT C very limited populations, expert consensus opinion 2

3 Guidelines Don t Just Happen f Are the Guidelines Perfect? JAMA 2009;301: In the 16 current guidelines: Only 11% of all recommendations were LOE = A 48% LOE C Only 19% of Class I recommendations were LOE = A The Link Between CPGs and the NCDR Science -tells us what we cando; Guidelines tells us what we shoulddo; Then how do we know what we are doing? Are we following the guidelines? Are we improving outcomes for patients? Roe MT, et al. J Am Coll Cardiol :56:254 :56:

4 Clinical Outcomes? We can only manage what we measure The Link Between CPGs and the NCDR Science -tell us what we cando; Guidelines tell us what we shoulddo; Registries -tell us what we aredoing The clinical yardstick of our performance The Link Between CPGs and the NCDR Science -tells us what we can do; Guidelines tells us what we should do; Registries -tells us what we are actually doing Examined: 131,980 STEMI and NSTEMI patients from ACTION-GWTG Registry 1,708,247 patients from the Cath PCI Registry Roe MT, et al. J Am Coll Cardiol :56:254 :56:

5 Registries Tell Us What We Are Doing We Are Improving! AMI Performance Composite Trend STEMI trend p value < NSTEMI trend p value < AMI Defect Free Care Trend STEMI trend p value < NSTEMI trend p value < AMI Risk-Adjusted Mortality Trend STEMI trend p value < NSTEMI trend p value < NCDR Contributions to CPGs NCDR model for in-hospital mortality cited Peterson ED, et al. Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry. J Am Coll Cardiol. 2010;55: NCDR Helps Change CPG NCDR CathPCI Registry Data: January 2004 March ,429 patients at 405 facilities with on-site surgery 8,736 patients at 60 facilities without onsite surgery J Am Coll Cardiol 2009;54:

6 Class IIb Class III Data from 14,821 patients from the ACTION-GWTG Registry Median DIDO time was 68 minutes with only 11% < 30 minutes Analysis of 412,617 PCIs STEMI excluded Grouped by Guideline indication class Circulation 2005;112:

7 Relationship Between Procedure Indications and Outcomes of PCI by ACC/AHA Guidelines % All p<0.001 MI CABG Death Class I Class IIa Class IIb Class III Anderson et al. Circulation 2005; 112:2786 The Feedback Cycle Clinical Trials Guidelines Performance Measures AUC Measurement New Gaps Identified Registries Adapted from: Califf RM, et al. J Am Coll Cardiol 2002; 40: When the Referee does this in football it means... 7

8 Remember, without your contributions, there would be no.... 8

ACTION Registry GWTG Research and Publications Update

ACTION Registry GWTG Research and Publications Update ACTION Registry GWTG Research and Publications Update Dr. Michael Kontos Director, Coronary Intensive Care Unit Pauley Heart Center, Virginia Commonwealth University The following relationships exist:

More information

The Evolving ACC-NCDR Programs: What you need to know for your practice

The Evolving ACC-NCDR Programs: What you need to know for your practice The Evolving ACC-NCDR Programs: What you need to know for your practice John S. Rumsfeld, MD PhD FACC Chief Science Officer and Chair, American College of Cardiology National Cardiovascular Data Registry

More information

Transfer in D2B. Scott D Friedman, MD FACC Medical Director, Cardiology Services Shore Health System of Maryland. The Problem

Transfer in D2B. Scott D Friedman, MD FACC Medical Director, Cardiology Services Shore Health System of Maryland. The Problem Transfer in D2B Scott D Friedman, MD FACC Medical Director, Cardiology Services Shore Health System of Maryland The Problem NRMI-5: North Carolina, July 2003- June 2004 NC Nation Guidelines N 2,738 79,927

More information

Daily practice of ACS management in the Gulf: Data from Gulf COAST

Daily practice of ACS management in the Gulf: Data from Gulf COAST Daily practice of ACS management in the Gulf: Data from Gulf COAST Mohammad Zubaid, MB, ChB, FRCPC, FACC Professor of Medicine, Kuwait University Head, Division of Cardiology Mubarak Alkabeer Hospital

More information

CathPCI Registry Poster Abstract

CathPCI Registry Poster Abstract CathPCI Registry Poster Abstract Topic of Poster: Quality Improvement Initiative Title: Process Improvement to Meet Appropriate Use Criteria (AUC) for Elective Patients in the National Cardiovascular Data

More information

Timing of Surgery After Percutaneous Coronary Intervention

Timing of Surgery After Percutaneous Coronary Intervention Timing of Surgery After Percutaneous Coronary Intervention Deepak Talreja, MD, FACC Bayview/EVMS/Sentara Outline/Highlights Timing of elective surgery What to do with medications Stopping anti-platelet

More information

Sanford Chest Pain Network: Improving Rural STEMI Outcomes

Sanford Chest Pain Network: Improving Rural STEMI Outcomes Sanford Chest Pain Network: Improving Rural STEMI Outcomes Naveen Rajpurohit, MD Cardiovascular Fellow Sanford Cardiovascular Institute Sanford Heart Hospital The University of South Dakota Sioux Falls,

More information

Ischemic Heart Disease Interventional Treatment

Ischemic Heart Disease Interventional Treatment Ischemic Heart Disease Interventional Treatment Cardiac Catheterization Laboratory Procedures (N = 89) is a regional and national referral center for percutaneous coronary intervention (PCI). A total of

More information

Cardiothoracic Department October 9, Deborah Winters, RN BSN Clinical Excellence

Cardiothoracic Department October 9, Deborah Winters, RN BSN Clinical Excellence Cardiothoracic Department October 9, 2013 Deborah Winters, RN BSN Clinical Excellence Quarterly Executive Summary CathPCI Registry PCI Performance Measures PCI Process/Outcome Metrics Diagnostic Cath Process/Outcome

More information

Culprit PCI vs MultiVessel PCI for Acute Myocardial Infarction

Culprit PCI vs MultiVessel PCI for Acute Myocardial Infarction Culprit PCI vs MultiVessel PCI for Acute Myocardial Infarction Dipti Itchhaporia, MD, FACC, FESC Trustee, American College of Cardiology Director of Disease Management, Hoag Hospital Robert and Georgia

More information

Ischemic Heart Disease Interventional Treatment

Ischemic Heart Disease Interventional Treatment Ischemic Heart Disease Interventional Treatment Cardiac Catheterization Laboratory Procedures (N = 11,61) is a regional and national referral center for percutaneous coronary intervention (PCI). A total

More information

REFERRAL HOSPITAL. The Importance of Door In Door Out Time DIDO

REFERRAL HOSPITAL. The Importance of Door In Door Out Time DIDO REFERRAL HOSPITAL The Importance of Door In Door Out Time DIDO Jean Skonhovd,RN,BSN,MSAS Emergency Department Director Avera Heart Hospital of South Dakota Time to Treatment is critical for STEMI patients

More information

10-Year Mortality of Older Acute Myocardial Infarction Patients Treated in U.S. Community Practice

10-Year Mortality of Older Acute Myocardial Infarction Patients Treated in U.S. Community Practice 10-Year Mortality of Older Acute Myocardial Infarction Patients Treated in U.S. Community Practice Ajar Kochar, MD on behalf of: Anita Y. Chen, Puza P. Sharma, Neha J. Pagidipati, Gregg C. Fonarow, Patricia

More information

Introduction to Acute Mechanical Circulatory Support

Introduction to Acute Mechanical Circulatory Support Introduction to Acute Mechanical Circulatory Support Navin K. Kapur, MD, FACC, FSCAI, FAHA Associate Professor, Department of Medicine Interventional Cardiology & Advanced Heart Failure Programs Executive

More information

2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease

2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease Developed in Collaboration with American Association for Thoracic Surgery, American

More information

Comparing Effectively: The Role of Registries in Comparative Effectiveness Research

Comparing Effectively: The Role of Registries in Comparative Effectiveness Research Comparing Effectively: The Role of Registries in Comparative Effectiveness Research National Comparative Effectiveness Summit Washington DC September 16, 2009 Ralph Brindis, MD, MPH, FACC, FSCAI President-

More information

Recommendations for criteria for STEMI systems of care: A focus on pharmacoinvasive strategies

Recommendations for criteria for STEMI systems of care: A focus on pharmacoinvasive strategies Recommendations for criteria for STEMI systems of care: A focus on pharmacoinvasive strategies Mohammad Zubaid, MB, ChB, FRCPC, FACC Professor of Medicine, Kuwait University Chairman, Faculty of Cardiology,

More information

Management of ST-elevation myocardial infarction Update 2009 Late comers: which options?

Management of ST-elevation myocardial infarction Update 2009 Late comers: which options? European Society of Cardiology Annual Session 2009 Management of ST-elevation myocardial infarction Update 2009 Late comers: which options? Antonio Abbate, MD Assistant Professor of Medicine Virginia Commonwealth

More information

Acute Coronary Syndrome. Sonny Achtchi, DO

Acute Coronary Syndrome. Sonny Achtchi, DO Acute Coronary Syndrome Sonny Achtchi, DO Objectives Understand evidence based and practice based treatments for stabilization and initial management of ACS Become familiar with ACS risk stratification

More information

Version 4.4. Institutional Outcomes Report 2014Q3. National Outcomes Report Aggregation Date: Jan 12, :59:59 PM

Version 4.4. Institutional Outcomes Report 2014Q3. National Outcomes Report Aggregation Date: Jan 12, :59:59 PM Version 4.4 Institutional Outcomes Report 2014Q3 National Outcomes Report 999997 Aggregation Date: Jan 12, 2015 11:59:59 PM Publish Date: Jan 29, 2015 If User desires to publish or otherwise distribute

More information

Pragmatic Trial Design to Study Health Policy Interventions: Lessons Learned from ARTEMIS Tracy Y. Wang, MD, MHS, MSc, FACC, FAHA

Pragmatic Trial Design to Study Health Policy Interventions: Lessons Learned from ARTEMIS Tracy Y. Wang, MD, MHS, MSc, FACC, FAHA Pragmatic Trial Design to Study Health Policy Interventions: Lessons Learned from ARTEMIS Tracy Y. Wang, MD, MHS, MSc, FACC, FAHA Associate Professor of Medicine, Duke University Director of Health Services

More information

Pharmaco-Invasive Approach for STEMI

Pharmaco-Invasive Approach for STEMI Pharmaco-Invasive Approach for STEMI Michael C. Kontos, MD Medical Director, Coronary Intensive Care Unit Director, Chest Pain Evaluation Center Associate Professor Departments of Internal Medicine (Cardiology),

More information

Controversies in Coronary Revascularization. Atlanta CCU April 15, 2016

Controversies in Coronary Revascularization. Atlanta CCU April 15, 2016 Controversies in Coronary Revascularization Atlanta CCU April 15, 2016 Habib Samady MD FACC FSCAI Professor of Medicine Director, Interventional Cardiology, Emory University Director, Cardiac Catheterization

More information

The Window for Fibrinolysis. Frans Van de Werf, MD, PhD Leuven, Belgium

The Window for Fibrinolysis. Frans Van de Werf, MD, PhD Leuven, Belgium The Window for Fibrinolysis Frans Van de Werf, MD, PhD Leuven, Belgium ESC STEMI Guidelines : December 2008 Reperfusion Therapy: Fibrinolytic Therapy Recommendations Class LOE In the absence of contraindications

More information

Managing Quality of ACS Care in VHA The IDH Guideline Key Points and Metrics

Managing Quality of ACS Care in VHA The IDH Guideline Key Points and Metrics Managing Quality of ACS Care in VHA The IDH Guideline Key Points and Metrics Robert L. Jesse, MD, PhD National Program Director for Cardiology Veterans Health Administration Washington, DC Chief, Cardiology

More information

Rationale for Left Ventricular Support During Percutaneous Coronary Intervention

Rationale for Left Ventricular Support During Percutaneous Coronary Intervention Rationale for Left Ventricular Support During Percutaneous Coronary Intervention Navin K. Kapur, MD, FACC, FSCAI Associate Professor, Division of Cardiology Director, Acute Circulatory Support Program

More information

National Cardiovascular Data Registry

National Cardiovascular Data Registry National Cardiovascular Data Registry Young and Early Career Investigators ACC/AGS/NIA Multimorbidity in Older Adults with Cardiovascular Disease Workshop Ralph Brindis, MD MPH Senior Medical Officer,

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Valle JA, Tamez H, Abbott JD, et al. Contemporary use and trends in unprotected left main coronary artery percutaneous coronary intervention in the United States: an analysis

More information

Left Main Intervention: Will it become standard of care?

Left Main Intervention: Will it become standard of care? Left Main Intervention: Will it become standard of care? David Cox, MD FSCAI, FACC Director, Interventional Cardiology Research Associate Director, Cardiac Cath Lab Lehigh Valley Health Network Allentown,

More information

PCI Guidelines: Essentials for Understanding the Appropriate Use Criteria. J. Jeffrey Marshall, MD, FSCAI

PCI Guidelines: Essentials for Understanding the Appropriate Use Criteria. J. Jeffrey Marshall, MD, FSCAI PCI Guidelines: Essentials for Understanding the Appropriate Use Criteria J. Jeffrey Marshall, MD, FSCAI December 8, 2013 Disclosures None PCI Guidelines: Essentials for Understanding the Appropriate

More information

What are the most common clinical scenarios that cause a PCI case to be deemed INAPPROPRIATE by AUC?

What are the most common clinical scenarios that cause a PCI case to be deemed INAPPROPRIATE by AUC? What are the most common clinical scenarios that cause a PCI case to be deemed INAPPROPRIATE by AUC? Michael A. Kutcher, MD, FSCAI Henry S. Jennings, III, MD, FSCAI The SCAI-Quality Improvement Toolkit

More information

Chronic Total Occlusions Rajan Patel, MD FACC FAHA FSCAI

Chronic Total Occlusions Rajan Patel, MD FACC FAHA FSCAI Chronic Total Occlusions Rajan Patel, MD FACC FAHA FSCAI Senior Lecturer Univ. of Queensland Ochsner Clinical School Ochsner Medical Center New Orleans, LA Overview I. Epidemiology II. Outcome Data

More information

News the. Methods Data collection. The NCDR is a national registry of patients undergoing diagnostic cardiac catheterizations

News the. Methods Data collection. The NCDR is a national registry of patients undergoing diagnostic cardiac catheterizations Journal of the American College of Cardiology Vol. 52, No. 20, 2008 2008 by the American College of Cardiology Foundation ISSN 0735-1097/08/$34.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2008.08.017

More information

William D. Salerno, M.D. Director, Coronary Care Unit Hackensack University Medical Center Clinical Associate Professor of Medicine, UMDNJ

William D. Salerno, M.D. Director, Coronary Care Unit Hackensack University Medical Center Clinical Associate Professor of Medicine, UMDNJ William D. Salerno, M.D. Director, Coronary Care Unit Hackensack University Medical Center Clinical Associate Professor of Medicine, UMDNJ PROBLEM: blood supply to the heart has been compromised and heart

More information

What do the guidelines say?

What do the guidelines say? Percutaneous coronary intervention in 3-vessel disease and main stem What do the guidelines say? Nothing to disclose Dariusz Dudek Institute of Cardiology, Jagiellonian University Krakow, Poland The European

More information

Clinical Research State of the Art A View as a Clinical Trialist,, Registry Researcher, Educator, Physician

Clinical Research State of the Art A View as a Clinical Trialist,, Registry Researcher, Educator, Physician Clinical Research State of the Art A View as a Clinical Trialist,, Registry Researcher, Educator, Physician Christopher Cannon, MD TIMI Study Group, Cardiovascular Division, Brigham and Women s Hospital,

More information

Rationale for Prophylactic Support During Percutaneous Coronary Intervention

Rationale for Prophylactic Support During Percutaneous Coronary Intervention Rationale for Prophylactic Support During Percutaneous Coronary Intervention Navin K. Kapur, MD, FACC, FSCAI Assistant Director, Interventional Cardiology Director, Interventional Research Laboratories

More information

Intro to Science & Quality. Prepared for Emerging Faculty September 2014 Julia Chang, VP Science & Quality

Intro to Science & Quality. Prepared for Emerging Faculty September 2014 Julia Chang, VP Science & Quality Intro to Science & Quality Prepared for Emerging Faculty September 2014 Julia Chang, VP Science & Quality jchang@acc.org Science & Quality A division within the College ACC Science & Quality Education

More information

Left Main Intervention: Where are we in 2015?

Left Main Intervention: Where are we in 2015? Left Main Intervention: Where are we in 2015? David A. Cox, MD FSCAI Director, Cardiology Research Associate Director, Cardiac Cath Lab Lehigh Valley Health Network Allentown, PA Fall Fellows Course Laa

More information

2013, American Heart Association

2013, American Heart Association 2013, American Heart Association Mission: Lifeline - Data, Reports and ACTION Registry - GWTG THE MISSION: BETTER HEART ATTACK CARE FOR YOUR COMMUNITY THE LIFELINE: THE AMERICAN HEART ASSOCIATION AND YOU

More information

Acute Coronary Syndromes: Different Continents, Different Guidelines?

Acute Coronary Syndromes: Different Continents, Different Guidelines? Acute Coronary Syndromes: Different Continents, Different Guidelines? Robert A. Harrington MD, MACC, FAHA, FESC Arthur L. Bloomfield Professor of Medicine Chair, Department of Medicine Stanford University

More information

Quality Improvement in the Cath Lab Today and Tomorrow. Sunil V. Rao MD The Duke Clinical Research Institute Duke University Medical Center

Quality Improvement in the Cath Lab Today and Tomorrow. Sunil V. Rao MD The Duke Clinical Research Institute Duke University Medical Center Quality Improvement in the Cath Lab Today and Tomorrow Sunil V. Rao MD The Duke Clinical Research Institute Duke University Medical Center Disclosures Consultant, Honoraria ZOLL, BMS, The Medicines Company,

More information

Asian AMI Registry Session The 17 th Joint Meeting of Coronary Revascularization (JCR 2017) Busan, Korea Dec 8 th 2017

Asian AMI Registry Session The 17 th Joint Meeting of Coronary Revascularization (JCR 2017) Busan, Korea Dec 8 th 2017 Asian AMI Registry Session The 17 th Joint Meeting of Coronary Revascularization (JCR 2017) Busan, Korea Dec 8 th 2017 Trends of acute myocardial infarction in Korea from the experience of Korea Acute

More information

STEMI Linee guida ESC Maddalena Lettino, Italy

STEMI Linee guida ESC Maddalena Lettino, Italy STEMI Linee guida ESC 2017 Maddalena Lettino, Italy Disclosure Speaker fee: Aspen, Astra Zeneca, BMS, Boehringer, Eli Lilly, DaichiiSankio, Bayer, Pfizer, Sanofi Advisory board member: Astra Zeneca, Eli

More information

Awealth of research in acute coronary syndrome

Awealth of research in acute coronary syndrome CLINICAL TRIAL SUPPORT OF THE USE OF CRITICAL PATHWAYS IN IMPROVING PATIENT OUTCOMES Judy W. M. Cheng, PharmD, MPH, BCPS, FCCP * ABSTRACT Acute coronary syndrome (ACS) is a common condition encountered

More information

The Future of Oral Antiplatelets in PAD and CAD Christopher Paris, MD, FACC, FSCAI

The Future of Oral Antiplatelets in PAD and CAD Christopher Paris, MD, FACC, FSCAI The Future of Oral Antiplatelets in PAD and CAD Christopher Paris, MD, FACC, FSCAI Interventional Cardiologist Cardiovascular Institute of the South Director of Cardiovascular Services St. Charles Parish

More information

Dual Antiplatelet Therapy Made Practical

Dual Antiplatelet Therapy Made Practical Dual Antiplatelet Therapy Made Practical David Parra, Pharm.D., FCCP, BCPS Clinical Pharmacy Program Manager in Cardiology/Anticoagulation VISN 8 Pharmacy Benefits Management Clinical Associate Professor

More information

Management of STEMI in era of Reperfusion. Eagles Peter Moyer, MD, MPH Medical Director Boston EMS, Fire and Police

Management of STEMI in era of Reperfusion. Eagles Peter Moyer, MD, MPH Medical Director Boston EMS, Fire and Police Management of STEMI in era of Reperfusion Eagles 2007 Peter Moyer, MD, MPH Medical Director Boston EMS, Fire and Police STEMI in US ST Segment Elevation Myocardial Infarction (STEMI) ~500 K per year Thrombolysis

More information

Do Clinical Practice Guidelines Improve Outcomes?

Do Clinical Practice Guidelines Improve Outcomes? Do Clinical Practice Guidelines Improve Outcomes? Canadian Cardiovascular HArmonization of National Guidelines Endeavour James A. Stone BPHE, BA, MSc, MD, PhD, FRCPC, FAACVPR, FACC Clinical Professor of

More information

Cardiogenic Shock and Initiatives to Reduce Mortality

Cardiogenic Shock and Initiatives to Reduce Mortality Cardiogenic Shock and Initiatives to Reduce Mortality Tanveer Rab, MD, FACC William O Neill, MD, FACC Perwaiz Meraj, MD, FACC Alex Truesdell, MD, FACC The Golden Hours? 50% dead within 10 hours Overall

More information

Dashboard and Outcomes Report with Case Studies

Dashboard and Outcomes Report with Case Studies Dashboard and Outcomes Report with Case Studies Kim Hustler Clinical Quality Consultant, American College of Cardiology The following relationships exist: Kim Hustler: No Disclosures Section F- Procedures

More information

The use of percutaneous coronary intervention

The use of percutaneous coronary intervention Elective PCI Without On-Site Cardiac : Standard of Care? The performance of PCI without on-site cardiac surgery remains controversial and continues to be debated in the US. BY GREGORY J. DEHMER, MD Although

More information

National Efforts to Improve Door-to-Balloon Time

National Efforts to Improve Door-to-Balloon Time Journal of the American College of Cardiology Vol. 54, No. 25, 2009 2009 by the American College of Cardiology Foundation ISSN 0735-1097/09/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2009.11.003

More information

David A. Orsinelli, MD, FACC, FASE Professor, Internal Medicine The Ohio State University Division of Cardiovascular Medicine Columbus, Ohio

David A. Orsinelli, MD, FACC, FASE Professor, Internal Medicine The Ohio State University Division of Cardiovascular Medicine Columbus, Ohio 1 STABLE ISCHEMIC HEART DISEASE: A NON-INVASIVE CARDIOLOGIST S PERSECTIVE 2018 Cardiovascular Course for Trainees and Early Career Physicians APRIL 20, 2018 David A. Orsinelli, MD, FACC, FASE Professor,

More information

Vascular Access Safety Training: The VAST Agenda

Vascular Access Safety Training: The VAST Agenda Vascular Access Safety Training: The VAST Agenda Mitchell W. Krucoff MD, FACC Professor of Medicine / Cardiology Duke University Medical Center Director, Cardiovascular Devices Unit Duke Clinical Research

More information

Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes

Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes Seung-Jae Joo and other KAMIR-NIH investigators Department of Cardiology, Jeju National

More information

Physician Self-referral and Health Care Utilization. Rita F. Redberg, MD, MSc Professor of Medicine UCSF Medical Center

Physician Self-referral and Health Care Utilization. Rita F. Redberg, MD, MSc Professor of Medicine UCSF Medical Center Physician Self-referral and Health Care Utilization Rita F. Redberg, MD, MSc Professor of Medicine UCSF Medical Center Physician self-referral why should we care? Extent of occurrences Impact of physician

More information

Facilitated Percutaneous Coronary Intervention in Acute Myocardial Infarction. Is it beneficial to patients?

Facilitated Percutaneous Coronary Intervention in Acute Myocardial Infarction. Is it beneficial to patients? Facilitated Percutaneous Coronary Intervention in Acute Myocardial Infarction Is it beneficial to patients? Seung-Jea Tahk, MD. PhD. Suwon, Korea Facilitated PCI.. background Degree of coronary flow at

More information

presenters 2010 Sameh Sabet Ain Shams University

presenters 2010 Sameh Sabet Ain Shams University Guidelines for PCI in late STEMI presenters 2010 Sameh Sabet Assistant Professor of Cardiology Ain Shams University 29% of MI patients have STEMI. NRMI 4 (Fourth National Registry of Myocardial Infarction),

More information

Διάρκεια διπλής αντιαιμοπεταλιακής αγωγής. Νικόλαος Γ.Πατσουράκος Καρδιολόγος, Επιμελητής Α ΕΣΥ Τζάνειο Γενικό Νοσοκομείο Πειραιά

Διάρκεια διπλής αντιαιμοπεταλιακής αγωγής. Νικόλαος Γ.Πατσουράκος Καρδιολόγος, Επιμελητής Α ΕΣΥ Τζάνειο Γενικό Νοσοκομείο Πειραιά Διάρκεια διπλής αντιαιμοπεταλιακής αγωγής Νικόλαος Γ.Πατσουράκος Καρδιολόγος, Επιμελητής Α ΕΣΥ Τζάνειο Γενικό Νοσοκομείο Πειραιά International ACS guidelines: Recommendations on duration of dual

More information

Benefit of Performing PCI Based on FFR

Benefit of Performing PCI Based on FFR Benefit of Performing PCI Based on FFR William F. Fearon, MD Associate Professor Director, Interventional Cardiology Stanford University Medical Center Benefit of FFR-Guided PCI FFR-Guided PCI vs. Angiography-Guided

More information

Further Evolution of the ACC/AHA Clinical Practice Guideline Recommendation Classification System

Further Evolution of the ACC/AHA Clinical Practice Guideline Recommendation Classification System Further Evolution of the ACC/AHA Clinical Practice Guideline Recommendation Classification System A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice

More information

Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study

Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study Tracy Y. Wang, MD, MHS, MSc, FACC, FAHA presenting on behalf of ARTEMIS Investigators Guidelines DAPT

More information

Preoperative Cardiac Risk Assessment: Approach & Guidelines

Preoperative Cardiac Risk Assessment: Approach & Guidelines Preoperative Cardiac Risk Assessment: Approach & Guidelines By, Liam Morris, MD., FACC (02/03/18) CPG : Clinical Practice Guidelines GDMT : Guidelines Directed Medical Therapy GWC : Guideline Writing Committee

More information

Mitigating Operator Risk in Complex Interventional Procedures. Tanveer Rab, MD, FACC Ajay Kirtane, MD, FACC Prashant Kaul, MD, FACC

Mitigating Operator Risk in Complex Interventional Procedures. Tanveer Rab, MD, FACC Ajay Kirtane, MD, FACC Prashant Kaul, MD, FACC Mitigating Operator Risk in Complex Interventional Procedures Tanveer Rab, MD, FACC Ajay Kirtane, MD, FACC Prashant Kaul, MD, FACC Risk assessment Documentation Informed consent Public reporting Steps

More information

STEMI update. Vijay Krishnamoorthy M.D. Interventional Cardiology

STEMI update. Vijay Krishnamoorthy M.D. Interventional Cardiology STEMI update Vijay Krishnamoorthy M.D. Interventional Cardiology OVERVIEW Current Standard of Care in Management of STEMI Update in management of STEMI Pre-Cath Lab In the ED/Office/EMS. Cath Lab Post

More information

Supplement. NHLBI and ACC/AHA Criteria for Rating Strength of Evidence

Supplement. NHLBI and ACC/AHA Criteria for Rating Strength of Evidence Supplement. NHLBI and ACC/AHA Criteria for Rating Strength of Evidence All recommendations were issued grades reflecting both the strength of the recommendation (Table 1) and the strength of the underlying

More information

Disclosures. Theodore A. Bass MD, FSCAI. The following relationships exist related to this presentation. None

Disclosures. Theodore A. Bass MD, FSCAI. The following relationships exist related to this presentation. None SCAI Fellows Course December 10, 2013 Disclosures Theodore A. Bass MD, FSCAI The following relationships exist related to this presentation None Current Controversies on DAPT in PCI Which drug? When to

More information

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form Last Updated: Version 4.4 NQF-ENORSE VOLUNTARY CONSENSUS STANARS FOR HOSPITAL CARE Measure Information Form Measure Set: Acute Myocardial Infarction (AMI) Set Measure I#: Performance Measure Name: Primary

More information

David E. Kandzari, MD Director, Interventional Cardiology Research Scripps Clinic La Jolla, California

David E. Kandzari, MD Director, Interventional Cardiology Research Scripps Clinic La Jolla, California 38 RCTs 18,000 pts Identifying the Optimal Duration of DAPT Less is More, More or Less David E. Kandzari, MD Director, Interventional Cardiology Research Scripps Clinic La Jolla, California kandzari.david@scrippshealth.org

More information

Stephan Windecker Department of Cardiology Swiss Cardiovascular Center and Clinical Trials Unit Bern Bern University Hospital, Switzerland

Stephan Windecker Department of Cardiology Swiss Cardiovascular Center and Clinical Trials Unit Bern Bern University Hospital, Switzerland Advances in Antiplatelet Therapy in PCI and ACS Stephan Windecker Department of Cardiology Swiss Cardiovascular Center and Clinical Trials Unit Bern Bern University Hospital, Switzerland Targets for Platelet

More information

Mark C. Bieniarz, MD Andrew Harrell, MD Peter Berger, MD

Mark C. Bieniarz, MD Andrew Harrell, MD Peter Berger, MD Mark C. Bieniarz, MD Andrew Harrell, MD Peter Berger, MD Should PCI center activate the cathlab off EMS field interpretation of ECG? Is this happening consistently in New Mexico? What is acceptable rate

More information

CABG vs PCI: What do the Guidelines Say?

CABG vs PCI: What do the Guidelines Say? AATS International Cardiovascular Symposium: Sao Paolo 2017 CABG vs PCI: What do the Guidelines Say? David P Taggart MD PhD FRCS FESC Professor of Cardiovascular Surgery, University of Oxford Conflicts

More information

Treatment of ST-elevation myocardial infarction in China: Where are we?

Treatment of ST-elevation myocardial infarction in China: Where are we? Treatment of ST-elevation myocardial infarction in China: Where are we? Associate Professor, Yihong Sun, MD Peking University People s Hospital Beijing, China Disclosure conflict of Interest The Challenges

More information

Get With The Guidelines: Lessons for National Healthcare Improvement Programs

Get With The Guidelines: Lessons for National Healthcare Improvement Programs Get With The Guidelines: Lessons for National Healthcare Improvement Programs Gregg C. Fonarow, MD, FACC, FAHA, FHFSA Eliot Corday Professor of Cardiovascular Medicine and Science UCLA Division of Cardiology

More information

PCIs on Intermediate Lesions NCDR Cath-PCI Registry

PCIs on Intermediate Lesions NCDR Cath-PCI Registry Practical Application Of Coronary Physiology in The Cath Lab Talal T Attar, MD, MBA, FACC PCIs on Intermediate Lesions NCDR Cath-PCI Registry Fraction of stenoses 50-70% treated with PCI without further

More information

Anticoagulation therapy in acute coronary syndromes according to current guidelines

Anticoagulation therapy in acute coronary syndromes according to current guidelines Acute management of ACS Anticoagulation therapy in acute coronary syndromes according to current guidelines Marcin Grabowski, Marcin Leszczyk, Andrzej Cacko, Krzysztof J. Filipiak, Grzegorz Opolski 1 st

More information

Acute Coronary Syndrome. Cindy Baker, MD FACC Director Peripheral Vascular Interventions Division of Cardiovascular Medicine

Acute Coronary Syndrome. Cindy Baker, MD FACC Director Peripheral Vascular Interventions Division of Cardiovascular Medicine Acute Coronary Syndrome Cindy Baker, MD FACC Director Peripheral Vascular Interventions Division of Cardiovascular Medicine Topics Timing is everything So many drugs to choose from What s a MINOCA? 2 Acute

More information

The Role of DHMC as an ST Elevation Myocardial Infarction Receiving Center in a Regional STEMI Care Network:

The Role of DHMC as an ST Elevation Myocardial Infarction Receiving Center in a Regional STEMI Care Network: The Role of DHMC as an ST Elevation Myocardial Infarction Receiving Center in a Regional STEMI Care Network: Nathaniel Niles, MD CREST Symposium November 7th, 28 STEMI = Acute Coronary Thrombosis STEMI

More information

CARDIAC REHABILITATION

CARDIAC REHABILITATION CARDIAC REHABILITATION A N A B A R A C M D, P H D M E D S T A R H E A R T A N D V A S C U L A R I N S T I T U T E, M E D S T A R W A S H I N G T O N H O S P I T A L C E N T E R OBJECTIVES Rationale for

More information

3309 Risk-Standardized Survival Rate (RSSR) for In-Hospital Cardiac Arrest (American Heart Association)

3309 Risk-Standardized Survival Rate (RSSR) for In-Hospital Cardiac Arrest (American Heart Association) Memo March 8, 2018 To: NQF Members and the Public From: NQF Staff Re: Commenting Draft Report: National Voluntary Consensus Standards for Cardiovascular Background This report reflects the review of measures

More information

AATS STARS Meeting Miami Beach November 17, 2017

AATS STARS Meeting Miami Beach November 17, 2017 The New Surgical The Heart Ablation Hospital Guidelines AATS STARS Meeting Miami Beach November 17, 2017 The Heart Hospital Baylor Plano Plano, Texas James R. Edgerton, MD, FACS, FACC, FHRS Surgical Director

More information

CLINICIAN INTERVIEW RECOGNIZING ACS AND STRATIFYING RISK IN PRIMARY CARE. An interview with A. Michael Lincoff, MD, and Eric R. Bates, MD, FACC, FAHA

CLINICIAN INTERVIEW RECOGNIZING ACS AND STRATIFYING RISK IN PRIMARY CARE. An interview with A. Michael Lincoff, MD, and Eric R. Bates, MD, FACC, FAHA RECOGNIZING ACS AND STRATIFYING RISK IN PRIMARY CARE An interview with A. Michael Lincoff, MD, and Eric R. Bates, MD, FACC, FAHA Dr Lincoff is an interventional cardiologist and the Vice Chairman for Research

More information

Should All Patients Be Treated with Ace-inh /ARB after STEMI with Preserved LV Function?

Should All Patients Be Treated with Ace-inh /ARB after STEMI with Preserved LV Function? Should All Patients Be Treated with Ace-inh /ARB after STEMI with Preserved LV Function? Avi Shimony, MD, FESC Cardiology Division Soroka University Medical Center Ben-Gurion University, Beer-Sheva Disclosure

More information

Regional STEMI Transfer Systems: the Mayo and NC RACE Experiences

Regional STEMI Transfer Systems: the Mayo and NC RACE Experiences Regional STEMI Transfer Systems: the Mayo and NC RACE Experiences Dr. Henry H. Ting, Mayo Clinic College of Medicine Dr. James G. Jollis,, Duke University Medical Center Mayo Clinic STEMI System for Transferred

More information

Controversies in Cardiac Pharmacology

Controversies in Cardiac Pharmacology Controversies in Cardiac Pharmacology Thomas D. Conley, MD FACC FSCAI Disclosures I have no relevant relationships with commercial interests to disclose. 1 Doc, do I really need to take all these medicines?

More information

Original Article Impact of timing to coronary angiography in acute coronary syndrome on contemporary clinical practice

Original Article Impact of timing to coronary angiography in acute coronary syndrome on contemporary clinical practice Am J Cardiovasc Dis 2012;2(3):248-252 www.ajcd.us /ISSN:2160-200X/AJCD1204002 Original Article Impact of timing to coronary angiography in acute coronary syndrome on contemporary clinical practice Angela

More information

Professional Society Roles in Drug-Device Cardiac Safety

Professional Society Roles in Drug-Device Cardiac Safety Professional Society Roles in Drug-Device Cardiac Safety TREATT II Thinktank Silver Spring, MD March 7, 2011 Ralph Brindis, MD MPH FACC President, American College of Cardiology Senior Advisor for CV Disease

More information

From the a Duke Clinical Research Institute, Durham, NC, Singapore, Singapore,

From the a Duke Clinical Research Institute, Durham, NC, Singapore, Singapore, Comparison of percutaneous coronary intervention for previously treated versus de novo culprit lesions in acute myocardial infarction patients: insights from the National Cardiovascular Data Registry Chee

More information

Data Requirements. Accreditation for Cardiovascular Excellence Quality in Invasive Cardiovascular Care

Data Requirements. Accreditation for Cardiovascular Excellence Quality in Invasive Cardiovascular Care 2011 Data Requirements Accreditation for Cardiovascular Excellence Quality in Invasive Cardiovascular Care 2400 N Street NW, Suite 500 Washington, D.C. 20037-1153 T: 202-657-6859 1 1. 2. It is required

More information

National registries for quality improvement and research

National registries for quality improvement and research Swedish experiences: National registries for quality improvement and research Stefan James Professor of Cardiology Uppsala Clinical Research Centre Uppsala University Uppsala, Sweden Evidence based health

More information

Stent For Life, Egypt A Success Story. Hany Ragy MD, FSCAI NHI, Cairo,

Stent For Life, Egypt A Success Story. Hany Ragy MD, FSCAI NHI, Cairo, Stent For Life, Egypt A Success Story Hany Ragy MD, FSCAI NHI, Cairo, Egypt @hragy Stent For Life Initiative in Egypt Professor Mohamed Sobhy, MD, FACC, FESC Professor of Cardiology Department, Alexandria

More information

Trends in U.S. Cardiovascular Care: 2016 Report from 4 ACC National Cardiovascular Data Registries

Trends in U.S. Cardiovascular Care: 2016 Report from 4 ACC National Cardiovascular Data Registries Accepted Manuscript Trends in U.S. Cardiovascular Care: 2016 Report from 4 ACC National Cardiovascular Data Registries Frederick A. Masoudi, MD, MSPH, Angelo Ponirakis, PhD, James A. de Lemos, MD, James

More information

Incidence and Treatment for LM In-Stent

Incidence and Treatment for LM In-Stent Incidence and Treatment for LM In-Stent Restenosis Corrado Tamburino, MD, PhD Full Professor of Cardiology, Director of Postgraduate School of Cardiology Chief Cardiovascular Department, Director Cardiology

More information

Blue Distinction Centers for Cardiac Care 2018 Provider Survey

Blue Distinction Centers for Cardiac Care 2018 Provider Survey Blue Distinction Centers for Cardiac Care 2018 Provider Survey Printed version of this document is for reference purposes only. Paper copies of the Provider Survey and Team Table will not be accepted.

More information

STEMI AND MULTIVESSEL CORONARY DISEASE

STEMI AND MULTIVESSEL CORONARY DISEASE STEMI AND MULTIVESSEL CORONARY DISEASE ΤΣΙΑΦΟΥΤΗΣ Ν. ΙΩΑΝΝΗΣ ΕΠΕΜΒΑΤΙΚΟΣ ΚΑΡΔΙΟΛΟΓΟΣ Α ΚΑΡΔΙΟΛΟΓΙΚΗ ΝΟΣ ΕΡΥΘΡΟΥ ΣΤΑΥΡΟΥ IRA 30-50% of STEMI patients have additional stenoses other than the infarct related

More information

Chronic Total Occlusions. Stephen Cook, MD Medical Director, Cardiac Catheterization Laboratory Oregon Heart & Vascular Institute

Chronic Total Occlusions. Stephen Cook, MD Medical Director, Cardiac Catheterization Laboratory Oregon Heart & Vascular Institute Chronic Total Occlusions Stephen Cook, MD Medical Director, Cardiac Catheterization Laboratory Oregon Heart & Vascular Institute Financial Disclosures /see -tee-oh / abbr. Med. Chronic Total Occlusion,

More information

Coronary stenting: the appropriate use of FFR

Coronary stenting: the appropriate use of FFR Coronary stenting: the appropriate use of FFR Morton J. Kern, MD Professor of Medicine Chief of Cardiology LBVA Associate Chief Cardiology University California Irvine Orange, California To treat or not

More information

ACCP Cardiology PRN Journal Club

ACCP Cardiology PRN Journal Club ACCP Cardiology PRN Journal Club 1 Optimising Crossover from Ticagrelor to Clopidogrel in Patients with Acute Coronary Syndrome [CAPITAL OPTI-CROSS] Monique Conway, PharmD, BCPS PGY-2 Cardiology Pharmacy

More information

COURAGE to Leave Diseased Arteries Alone

COURAGE to Leave Diseased Arteries Alone COURAGE to Leave Diseased Arteries Alone Spencer King MD MACC, FSCAI St. Joseph s s Heart and Vascular Institute Professor of Medicine Emeritus Emory Univ. Atlanta, USA Conflict: I am an Interventionalist

More information